Pilot: Impact of High-Dose, Single Fraction Radiation on Immunogenicity of Sipuleucel-T in Metastatic Castration Recurrent Prostate Cancer Patients
Description: 

To assess whether RT increases the immunogenic potential or sipuleucel-T in patients with castration recurrent prostate cancer.

Study Number: 

I 223912

Phase: 
Pilot
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01833208

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.